Archive for June, 2008
There is new evidence linking risk for one kind of fracture with long-term use of bisphosphonates — drugs like Fosamax that are prescribed to treat osteoporosis in older persons by increasing bone density in order to prevent fractures. The findings are reported by Drs. Dean G. Lorich and Joseph M. Lane of NewYork-Presbyterian Hospital/Weill Cornell Medical Center in the latest issue of the Journal of Orthopaedic Trauma.
More: continued here
Patients who had complete hip replacement surgery, or total hiparthroplasty (THA), had better success at preventing venousthromboembolism if they used extended duration rivaroxaban instead ofshort-term enoxaparin plus placebo. The results of the full study byProfessor Ajay Kakkar (Barts and the London School of Medicine andDentistry and the Thrombosis Research Institute, London, UK) andcolleagues are published in The Lancet.
More: continued here
A McMaster University researcher predicts a new oral blood thinner will revolutionize treatment for preventing dangerous blood clots in patients undergoing hip and knee surgery. Dr. Alexander Turpie, professor of medicine in the Michael G. DeGroote School of Medicine, oversaw four major international studies on the drug rivaroxaban (Xarelto).
More: continued here
Patients suffering from severe arthritis now have an option for total ankle replacement that offers increased mobility and pain relief without permanent metal implants. Pioneered by Daniel K. Lee, D.P.M., F.A.C.F.A.S., at UC San Diego Medical Center, this technique is the first in the U.S to offer arthritis sufferers a non-metal, biological ankle replacement.
More: continued here
An ultrasound exam of the heel may be able to predict if a woman is at heightened risk for fractures due to osteoporosis, according to a new multicenter study being published in the July issue of the journal Radiology. Along with certain risk factors, including age or recent fall, radiation-free ultrasound of the heel may be used to better select women who need further bone density testing, such as a dual-energy x-ray absorptiometry (DXA) exam.
More: continued here
ArthroCare® Corp. (NASDAQ: ARTC) announced the launch of its new DoublePlay implant, a novel suture anchor device intended for soft tissue to bone fixation in surgical procedures such as rotator cuff repair. It is unique in terms of design and material. The DoublePlay device is a fully threaded anchor and features an “eyeless” design - a new concept in the world of screw-in anchors.
More: continued here
A new device that offers a more effective method of splinting for wrist fractures, devised by a Loughborough University designer and a consultant orthopaedic surgeon, has been awarded a grant from the Audi Design Foundation. The grant of £19,840 will now allow Loughborough lecturer George Torrens and John Dooley from Hillingdon Hospital to produce a prototype of the device, known as Fit-Splint, and enable an initial series of clinical trials to begin in early 2009.
More: continued here
Researchers from Stony Brook University Medical Center have found that women in the United States who have urinary cadmium levels that are below the U.S. Occupational Safety & Health Administration safety standard are at risk for osteoporosis.
More: continued here
New data suggest that patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg Cymbalta (duloxetine HCl) once daily experienced significant pain reduction. Patients taking duloxetine reported significant pain improvement compared to placebo within the first week of treatment that lasted throughout the 13-week trial.(1) Results from the study of 231 patients were presented at the annual congress of the European League Against Rheumatism (EULAR) in Paris, France.
More: continued here
DePuy Spine, Inc. introduced its next generation in anterior Cervical fixation: the EAGLE™ Plus Rigid and the SWIFT™ Plus Dynamic Anterior Cervical Plating (ACP) Systems, which now offer more plating options for anatomically challenging procedures and incorporate new screw locking technology.
More: continued here





